SavedAdd your journal

Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2019 / Cilt: 27 - Sayı: 4

The use of rivaroxaban in deep venous thrombosis associated with vena cava inferior agenesis

Vena kava inferior agenezisi ile ilişkili derin ven trombozunda rivaroksaban kullanımı

Ali Ahmet a
Selçuk EMRE
Bayraktar Fatih AVNİ
Pages
583–585
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we report an18-year-old male case with deep vein thrombosis associated withinferior vena cava agenesis who was on rivaroxaban as a lifelonganticoagulation treatment for symptoms of venous stasis and thepresence of heterozygotic thrombophilic mutations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Inferior vena cava agenesis is a rare anomaly which may resultin deep vein thrombosis.
📊
Key Findings & Data:There is no clear scientific evidence forthe most effective therapeutic management, optimal duration,or the choice of anticoagulant therapy.
💡
Conclusion & Impact:Herein, we report an18-year-old male case with deep vein thrombosis associated withinferior vena cava agenesis who was on rivaroxaban as a lifelonganticoagulation treatment for symptoms of venous stasis and thepresence of heterozygotic thrombophilic mutations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Inferior vena cava agenesis is a rare anomaly which may resultin deep vein thrombosis. There is no clear scientific evidence forthe most effective therapeutic management, optimal duration,or the choice of anticoagulant therapy. Herein, we report an18-year-old male case with deep vein thrombosis associated withinferior vena cava agenesis who was on rivaroxaban as a lifelonganticoagulation treatment for symptoms of venous stasis and thepresence of heterozygotic thrombophilic mutations.

Özet

İnferior vena kava agenezisi, derin ven trombozu ile sonuçlanabilen nadir bir anomalidir. En etkili tedavi yöntemi, optimum tedavi süresi ve antikoagülan seçimine ilişkin kesin bilimsel veri yoktur. Bu yazıda venöz staz semptomları ve heterozigot trombofilik mutasyonların varlığı nedeni ile yaşam boyu antikoagülasyon tedavisi olarak rivaroksaban verilen inferior vena kava agenezisi ile ilişkili derin ven trombozu olan 18 yaşında bir erkek olgu sunuldu.

🔖

Cite This Article

a, A. A., EMRE, S., AVNİ, B. F. (2022). The use of rivaroxaban in deep venous thrombosis associated with vena cava inferior agenesis. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 27 - Sayı: 4, 583–585. https://ajindex.com/articles/423744

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Gil RJ, Pérez AM, Arias JB, Pascual FB, Romero ES. Agenesis of the inferior vena cava associated with lower extremities and pelvic venous thrombosis. J Vasc Surg 2006;44:1114-6
  2. Yugueros X, Alvarez B, Fernández E, Boqué M, Matas M. Compressive symptoms due to thrombosed or hypertrophic collateral circulation in infrarenal inferior vena cava agenesis. Ann Vasc Surg 2013;27:238
  3. Khalafallah AA, Renu S, Sharp C, Hannan T. Extensive venous thrombosis in a healthy young man with a short inferior vena cava syndrome treated successfully with rivaroxaban. BMJ Case Rep 2012;2012
  4. Pozzi A, El Lakis MA, Chamieh J, Carbonell BB, Villa F. The typical presentation spectrum of deep vein thrombosis associated with inferior vena cava malformations. Thrombosis 2016;2016:4965458
  5. Pulanić D, Ranković E, Vodanović M, Lušić M, Boban A, Zupancić Šalek S, et al. Extensive deep venous thrombosis in a young male patient as the first manifestation of a rare venous anomaly - inferior vena cava duplication: Case report. Acta Clin Croat 2017;56:338-43
  6. Schierz IAM, Piro E, Giuffrè M, Pinello G, Corsello G. Dilated azygos arch mimicking an aortic arch anomaly during thoracic surgery. Early Hum Dev 2017;111:20-22
  7. Parsa P, Lane JS, Barleben AR, Owens EL, Bandyk D. Congenital agenesis of inferior vena cava: a rare cause of unprovoked deep venous thrombosis. Ann Vasc Surg 2015;29:1017.e15-8
  8. Bezgin T, Kaymaz C, Akbal Ö, Yılmaz F, Tokgöz HC, Özdemir N. Thrombophilic gene mutations in relation to different manifestations of venous thromboembolism: a single tertiary center study. Clin Appl Thromb Hemost 2018;24:100-6
  9. Tufano A, Cannavacciuolo F, Gianno A, Cerbone AM, Mangiacapra S, Coppola A, et al. Inferior vena cava agenesis and deep vein thrombosis in the young: a review of the literature and local experience. Semin Thromb Hemost 2017;43:827-35
  10. Aday AW, Sobieszczyk PS, Beckman JA. Absent at birth: An unusual case of deep vein thrombosis. Circulation 2016;133:1209-16
  11. Sagban TA, Grotemeyer D, Balzer KM, Tekath B, Pillny M, Grabitz K, et al. Surgical treatment for agenesis of the vena cava: a single-centre experience in 15 cases. Eur J Vasc Endovasc Surg 2010;40:241-5.